These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32518059)

  • 1. Corrigendum to "A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus" [Bioorg. Med. Chem. Lett. 27 (2017) 893-896].
    Zhou J; Feng JH; Robertson J; Fang L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127294. PubMed ID: 32518059
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus.
    Zhou J; Feng JH; Fang L
    Bioorg Med Chem Lett; 2017 Feb; 27(4):893-896. PubMed ID: 28119023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic indole alkaloids from Melodinus khasianus and Melodinus tenuicaudatus.
    Yi WF; Chen DZ; Ding X; Li XN; Li SL; Di YT; Zhang Y; Hao XJ
    Fitoterapia; 2018 Jul; 128():162-168. PubMed ID: 29772302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melokhanines A-J, Bioactive Monoterpenoid Indole Alkaloids with Diverse Skeletons from Melodinus khasianus.
    Cheng GG; Li D; Hou B; Li XN; Liu L; Chen YY; Lunga PK; Khan A; Liu YP; Zuo ZL; Luo XD
    J Nat Prod; 2016 Sep; 79(9):2158-66. PubMed ID: 27584856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities" [Bioorg. Med. Chem. Lett. 20(23) (2010) 7110-7115].
    Liang C; Ding Y; Nguyen HT; Kim JA; Boo HJ; Kang HK; Nguyen MC; Kim YH
    Bioorg Med Chem Lett; 2021 Jun; 41():128014. PubMed ID: 33867227
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Rotenoisin A is a novel anti-adipogenic compound" [Bioorg. Med. Chem. Lett. 29 (2018) 89-96].
    Cho HH; Park HS; Jang SH; Won C; Kim HD; Kim TH; Cho JH
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127295. PubMed ID: 32571641
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
    Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].
    Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
    Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Novel NanoLuc-type substrates with various C-6 substitutions" [Bioorg. Med. Chem. Lett. 30 (2020) 127085].
    Yan C; Du L; Li M
    Bioorg Med Chem Lett; 2021 May; 39():127940. PubMed ID: 33677042
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
    Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors" [Bioorg. Med. Chem. Lett. 30 (2020) 127551].
    Grädler U; Busch M; Leuthner B; Raba M; Burgdorf L; Lehmann M; Linde N; Esdar C
    Bioorg Med Chem Lett; 2021 Oct; 49():128262. PubMed ID: 34352662
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
    Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW
    Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
    Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK
    Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].
    Monteillier A; Loucif A; Omoto K; Stevens EB; Lainez S; Saintot PP; Cao L; Pryde DC
    Bioorg Med Chem Lett; 2017 May; 27(9):2082. PubMed ID: 28320618
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587].
    Yin J; Zhao Y; He Q; Hai A; Peng Y; Zuo Z; Gao L; Song Z; Ke B
    Bioorg Med Chem Lett; 2022 Jul; 68():128765. PubMed ID: 35525630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.